SLC7A11 and hepatocellular carcinoma: In hepatocellular carcinoma models, USP8 inhibition suppresses tumor growth and metastasis by inducing ferroptosis through OGT destabilization to disrupt OGT-SLC7A11 axis [15]; USP8 promotes cancer progression by stabilizing β-catenin and inhibiting ferroptosis [32].